What Fusion Scientific Technologies does

Fusion Scientific Technologies (also operating as Fusion Scientific Laboratories) is a privately held, founder-owned Contract Research Organisation founded in 2011 and headquartered in an 18,000 sq. ft. USFDA-approved facility in MIDC Rabale, Navi Mumbai, India. The company delivers three integrated service lines to global pharmaceutical clients: Formulation Development (using Quality-by-Design tools and Design of Experiment methodology across tablets, capsules, parenterals, ophthalmics, pellets, powders, and liquids), Analytical Solutions (method development, validation, dissolution, extractables/leachables, stability, and QC release testing on a hyphenated instrument fleet), and Integrated Pharmaceutical Solutions (end-to-end programs from patent evaluation and API sourcing through bioequivalence studies, regulatory support, and technology transfer to CMOs). Since 2015 the company has held USFDA approval and has accumulated product approvals in Australia, Canada, and China, with a 505(b)(2) USFDA filing made in 2022. The company also operates a pan-India distribution network for pre-clinical and biotech instruments from global vendors (Gyros Protein Technologies, Scintica, Bioemtech, Trifoil Imaging).

Revenue is generated primarily through professional service fees on contract research engagements and secondarily through margins on instrument distribution. Go-to-market is enterprise field sales with quote-based, customized pricing, supplemented by participation in CPHI Worldwide (Frankfurt) and CPHI India. The primary customer segment is global pharmaceutical companies seeking formulation and analytical services across multiple regulatory jurisdictions; a secondary segment is Indian pharmaceutical and biotech companies purchasing distributed instruments. Ownership is concentrated among the three founding Kotwani family members, with no institutional investor, private equity, or parent company involvement disclosed. The company is privately held, has no disclosed funding rounds, and operates with 51-100 employees.

Name

Fusion Scientific Technologies

Legal name

Fusion Scientific Laboratories

Website

https://fstin.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Process Development & Tech Transfer Services (CDMO) (HLAGABAL)

Keywords

• Pharmaceutical contract research
• Formulation development services
• Analytical method validation
• Bioequivalence studies
• Drug delivery solutions

Headquarters

HQ city

Ghansoli

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Contract Research Services: Provides pharmaceutical product development services including Formulation Development and Analytical Solutions to pharmaceutical companies on a contract basis. Revenue generated through service fees for drug development projects.
2. Instrument Distribution: Offers distribution network for preclinical and biotech instruments from global manufacturers pan India, generating revenue through sales commissions or margins.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Fusion Scientific Technologies is a USFDA-approved Contract Research Organisation that provides pharmaceutical formulation development (tablets, capsules, parenterals, ophthalmics, pellets, powders, liquids) using Quality-by-Design and Design of Experiment methodologies, comprehensive analytical method development and validation services, and integrated end-to-end pharmaceutical solutions from patent evaluation through technology transfer and commercial manufacturing. The company also distributes pre-clinical and biotech instruments from global manufacturers across India through its pan-India distribution network.

Product overview

Fusion Scientific Technologies operates as an independent Contract Research Organisation (CRO) providing a comprehensive suite of pharmaceutical development services. The core offering consists of three integrated service lines: Formulation Development (covering tablets, capsules, parenterals, ophthalmics, pellets, powders, and liquids using technologies such as dry blending, high shear granulation, fluid bed granulation, roller compaction, extrusion spheronisation, Wurster coating, spray drying, and pan coating), Analytical Solutions (encompassing method development, validation, cleaning methods, dissolution, extractable/leachable studies, and QC testing), and Integrated Pharmaceutical Solutions (providing end-to-end services from patent evaluation through commercial manufacturing). The company also distributes specialized pre-clinical and biotech instruments from global manufacturers including Gyros Protein Technologies, Scintica, Bioemtech, and Trifoil Imaging across India.

Differentiator

Problem solved

Functional benefit

Products and services

• Formulation Development Fit-for-purpose drug formulation development service using Quality-by-Design tools such as Design of Experiment (DOE) and risk assessment, targeting formulations with desired Critical Quality Attributes (CQA). Covers multiple dosage forms including tablets, capsules, parenterals, ophthalmics, pellets, powders, and liquids for pharmaceutical clients globally.
• Analytical Solutions Comprehensive analytical services including method development, validation, technology transfer, cleaning method development, dissolution studies, extractable and leachable studies, residual solvent studies, pharmacopoeial monograph testing, stability testing, and QC batch release testing for pharmaceutical companies.
• Integrated Pharmaceutical Solutions End-to-end pharmaceutical development services from conceptualization through commercial manufacturing, including dosage form design, patent survey, API sourcing, pre-formulation, bench and lab scale development, bioequivalence/bioavailability studies, regulatory support, and technology transfer to contract manufacturing organizations.
• Instrumentation Distribution Distribution of pre-clinical and biotech instruments from global manufacturers across India, including Gyros Protein Technologies peptides, Scintica MRI and imaging products, Bioemtech preclinical imaging products, and Trifoil Imaging products. Targeted at Indian pharmaceutical and biotech companies seeking access to advanced instrumentation.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• Gyros Protein TechnologiescoreChannel Partner/ Reseller/ DistributorProduct distribution partnership for peptides. Fusion Scientific distributes Gyros Protein Technologies products in the Indian market as part of their instrument distribution network.
• ScinticacoreChannel Partner/ Reseller/ DistributorProduct distribution partnership for imaging and MRI products. Scintica products are distributed through Fusion Scientific's pan-India distribution network.
• BioemtechcoreChannel Partner/ Reseller/ DistributorProduct distribution partnership for preclinical imaging products. Fusion Scientific distributes Bioemtech products in the Indian market.
• Trifoil ImagingcoreChannel Partner/ Reseller/ DistributorProduct distribution partnership for imaging products. Trifoil Imaging products are distributed through Fusion Scientific's pan-India distribution network.

Scale indicators5 records

Recent moves8 records

Expansion highlights4 records

Direct peers

• Jubilant Biosys: India-based contract research organization providing drug discovery, formulation, and analytical services to global pharmaceutical companies. Comparable in CRO service model, India cost base, and USFDA-aligned quality systems serving global pharma sponsors.
• Sai Life Sciences: India-based CRO/CDMO providing formulation development, analytical services, and integrated drug substance/product development to global pharma. Directly comparable in service portfolio, USFDA-aligned operations, and mid-tier positioning serving innovator and generic sponsors.
• Neuland Laboratories: India-based pharmaceutical CDMO with formulation development, analytical services, and API manufacturing for global generic and innovator customers. Comparable in USFDA approval, generic/505(b)(2) focus, and integrated development offerings.
• Aizant Drug Research Solutions: India-based contract research and development organization focused on formulation development, bioavailability/bioequivalence studies, and analytical services. Highly comparable as a similarly-sized USFDA-approved Indian CRO with overlapping formulation and analytical service offerings.
• Suven Life Sciences: India-based pharmaceutical CRO/CDMO offering formulation development, analytical method development/validation, and contract manufacturing. Directly comparable in CRO service model, 505(b)(2) and complex generic capabilities, and India-based USFDA-approved operations.

Broad incumbents

• Piramal Pharma Solutions: Global CDMO offering drug substance, drug product (formulation), and analytical services across multiple dosage forms. Comparable service mix to Fusion Scientific, particularly in integrated formulation and analytical offerings, though operating at a much larger multi-site scale.
• Syngene International: India's largest publicly listed CRO/CDMO offering formulation development, analytical services, and integrated drug development to global pharma. Comparable as a USFDA-approved Indian CRO serving global pharmaceutical sponsors with end-to-end development services, though at significantly greater scale.
• Eurofins Scientific: Global leader in bioanalytical and pharmaceutical testing services, including formulation support and analytical method development. Comparable in the analytical/CRO services domain, though operating at vastly larger global scale across many industries beyond pharma.
• Aragen Life Sciences (formerly GVK Biosciences): India-headquartered CRO/CDMO with formulation development, analytical, and integrated discovery-to-development services. Comparable as a USFDA-aligned Indian CRO serving global pharma, with a similar end-to-end service philosophy, though much larger headcount and global footprint.

Emerging players

• Vivan Life Sciences: India-based emerging CRO offering formulation development, analytical services, and regulatory support. Comparable service portfolio to Fusion Scientific, but typically serving smaller sponsors and earlier-stage programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fusion Scientific Technologies